Regorafenib in patients with refractory metastatic pancreatic cancer: a Phase II study (RESOUND).
Future Oncol
; 15(35): 4009-4017, 2019 Dec.
Article
in En
| MEDLINE
| ID: mdl-31746632
Full text:
1
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Phenylurea Compounds
/
Pyridines
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Future Oncol
Year:
2019
Type:
Article
Affiliation country:
Italy